En-tête de navigationNavigation principaleSuiviFiche


Unité de recherche
PCRD EU
Numéro de projet
97.0431
Titre du projet
Assessment of the occupational relevance of allergens based on their molecular structure, metabolism and cross reactivity to related chemical compounds
Titre du projet anglais
Assessment of the occupational relevance of allergens based on their molecular structure, metabolism and cross reactivity to related chemical compounds

Textes relatifs à ce projet

 AllemandFrançaisItalienAnglais
Mots-clé
-
-
-
Anzeigen
Autre Numéro de projet
-
-
-
Anzeigen
Programme de recherche
-
-
-
Anzeigen
Description succincte
-
-
-
Anzeigen
Autres indications
-
-
-
Anzeigen
Partenaires et organisations internationales
-
-
-
Anzeigen
Résumé des résultats (Abstract)
-
-
-
Anzeigen
Références bases de données
-
-
-
Anzeigen

Textes saisis


CatégorieTexte
Mots-clé
(Anglais)
Occupational allergens; drug allergy; cross reactivity; sulfonamides; T cell immunity
Autre Numéro de projet
(Anglais)
EU project number: BMH4CT983713
Programme de recherche
(Anglais)
EU-programme: 4. Frame Research Programme - 4.2 Agriculture and agroindustry
Description succincte
(Anglais)
See abstract
Autres indications
(Anglais)
Full name of research-institution/enterprise:
Inselspital Bern
Institut für Immunologie und Allergologie
Partenaires et organisations internationales
(Anglais)
Coordinator: Universitätsklinikum Aachen (D)
Résumé des résultats (Abstract)
(Anglais)
We recently established a model, that drug stimulation may also occur with drugs unable to bind in a covalent way to MHC peptide complexes. We demonstrated that chemically inert drugs are able to stimulate preactivated T cell clones and recently we found, that most likely also resting T cells are activated by non-covalently binding drugs. This implies, that drugs can be used as substances interacting with a specific T cell receptor and opens completely new ways in future therapeutic intervention in autoimmune or allergic diseases!
We analysed in detail the crossreactivity of such drug-stimulated T cells: We found, that drug stimulated T cells can interact with different, structurally related drugs, which require, however, a certain homology in the overall structure). The existence of a sulfonamide bridge within the drug is not sufficient to cause cross-reactivity . This has important implications for future therapies, as it is i.e. recommended that sulfomanide-containing drugs (like celecoxib, furosemide etc.) are avoided in persons sensitized to sulfonamide-antibiotics (i.e. Bactrimâ). This precaution appears to be unnecessary, if T cell reactions were relevant for the drug allergy. In addition, we found that drug-stimulated T cells react to a high degree with autologus structures . This has implications for drug induced autoimmunity .
Références bases de données
(Anglais)
Swiss Database: Euro-DB of the
State Secretariat for Education and Research
Hallwylstrasse 4
CH-3003 Berne, Switzerland
Tel. +41 31 322 74 82
Swiss Project-Number: 97.0431